The Estée Lauder Companies Inc. (EL) Stock Price & Analysis
The Estée Lauder Companies Inc. (EL) is trading at USD 107.97, up 0.23% today, as of October 23, 2026 at 17:27 UTC (US market open; quotes may be delayed), according to Nexqual market data.
EL last closed at USD 107.72; today's session has ranged USD 106.01–108.97 on volume of 1,771,548 shares. Market capitalization is $39.12B, with a 52-week range of USD 66.22–121.64 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 17:28 UTC.
Also available as compact Markdown for AI agents: nexqual.com/EL.md
Key facts (EL)
- Last four reported quarters (through Jun 30, 2026): revenue $15.0B, net income $182M (1.2% margin), free cash flow $1.32B (SEC filings).
- Valuation: P/E 214.9x (avg 126.0x at the last 2 fiscal year-ends), EV/EBITDA 27.2x, net debt $3.81B.
- 3 of 80 tracked superinvestors hold EL (13F, Q2 2026): 1 new, 0 added, 1 reduced, 1 unchanged.
- Analysts: Buy (mean 2.33 on a 1–5 scale) (30 analysts), mean target USD 109.7 (range 70–127).
- Total return with dividends: 1Y +10.1% vs S&P 500 +14.4%; 5Y -64.0% vs S&P 500 +77.0%.
- Next earnings: 2026-11-02, EPS estimate USD 0.51, revenue estimate $3.65B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (EL)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $17.7B | $15.9B | $15.6B | $14.3B | $15.0B | $15.0B |
| Gross profit | $13.4B | $11.3B | $11.2B | $10.6B | $11.4B | — |
| Operating income | $3.17B | $1.51B | $970M | -$785M | $780M | $780M |
| Net income | $2.41B | $1.01B | $409M | -$1.13B | $182M | $182M |
| EPS (diluted) | $6.55 | $2.79 | $1.08 | -$3.15 | $0.50 | — |
| Free cash flow | $2.00B | $728M | $1.44B | $670M | $1.32B | $1.32B |
| Gross margin | 75.7% | 71.3% | 71.7% | 74.0% | 75.5% | — |
| Operating margin | 17.9% | 9.5% | 6.2% | -5.5% | 5.2% | 5.2% |
| Net margin | 13.6% | 6.3% | 2.6% | -7.9% | 1.2% | 1.2% |
| Revenue growth | +9.4% | -10.3% | -1.9% | -8.2% | +5.0% | — |
| Cash + short-term investments | $3.96B | $4.03B | $3.40B | $2.92B | $3.50B | — |
| Total debt | $5.41B | $8.11B | $7.77B | $7.32B | $7.31B | — |
Fiscal years end Jun. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (EL)
P/E 214.9x · P/S 2.6x · EV/EBITDA 27.2x · EV/Sales 2.9x · P/FCF 29.7x · P/B 10.3x · FCF yield 3.36% · Earnings yield 0.47% · Dividend yield (paid, TTM) 1.30% · Buyback yield (TTM) 0.18% · Net debt $3.81B · EV $42.9B
P/E at fiscal year-ends: Jun 2026 158.2x, Jun 2024 93.9x.
Superinvestors (SEC 13F-HR, Q2 2026) (EL)
3 of 80 tracked investors hold EL. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Hillman Capital | Hillman Capital Management | 2.87% | $4.0M | Reduced -3.7% |
| Lindsell Train | 0.05% | $1.2M | Unchanged | |
| Lee Ainslie | Maverick Capital | <0.01% | $253K | New position |
Analysts (EL)
Consensus Buy (mean 2.33 on a 1–5 scale), 30 analysts; mean target USD 109.7 (low 70, high 127).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-23 | Piper Sandler | Target raised | Overweight | $115 → $125 |
| 2026-10-22 | Canaccord Genuity | Target raised | Hold | $90 → $109 |
| 2026-10-19 | JP Morgan | Target raised | Overweight | $112 → $115 |
| 2026-10-19 | Jefferies | Target raised | Hold | $100 → $120 |
| 2026-10-15 | Morgan Stanley | Target raised | Equal-Weight | $102 → $112 |
| 2026-10-05 | Wells Fargo | Target lowered | Equal-Weight | $104 → $95 |
| 2026-10-05 | Barclays | Upgrade | Equal-Weight → Overweight | $97 → $108 |
| 2026-08-21 | Barclays | Target raised | Equal-Weight | $80 → $97 |
| 2026-08-20 | Jefferies | Target raised | Hold | $88 → $100 |
| 2026-08-20 | Canaccord Genuity | Target raised | Hold | $85 → $90 |
| 2026-08-20 | Telsey Advisory Group | Target raised | Market Perform | $90 → $108 |
| 2026-08-20 | Citigroup | Target raised | Buy | $110 → $115 |
Total return (dividends reinvested) (EL)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +10.1% | -64.0% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | +10.1% | -18.5% |
| Volatility (annualized) | 48.3% | 43.8% |
| Max drawdown | -43.6% (Feb 2026→Mar 2026) | -84.9% (Dec 2021→Mar 2025) |
EL revenue by region (fiscal year ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| All other countries | $7.37B | 49.0% | +6.6% |
| Mainland China | $3.93B | 26.1% | +7.6% |
| U.S. | $3.75B | 24.9% | -0.3% |
| Total revenue | $15.05B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
EL company outlook (results filed Aug 19, 2026)
- “Fiscal 2027 Outlook of Organic Net Sales Growth of 3% to 5%;”
- “Raises Outlook on Adjusted Operating Margin to 12.7% to 13.5% New York, August 19, 2026 - The Estée Lauder Companies Inc.”
- “(NYSE: EL) today reported its financial results for its fiscal year ended June 30, 2026. "I am incredibly proud of our team for delivering fiscal 2026 results ahead of the expectations we had to start the year.”
Quoted word-for-word from the SEC 8-K results press release.
EL analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.51 | $0.48 | +6.1% | $3.65B | 21 |
| Next quarter (ends Dec 2026) | $1.21 | $1.17 | +2.9% | $4.45B | 20 |
| Current fiscal year (ends Jun 2027) | $3.33 | $3.18 | +4.5% | $15.73B | 30 |
| Next fiscal year (ends Jun 2028) | $3.93 | $3.83 | +2.7% | $16.41B | 28 |
Key Statistics (as of October 23, 2026 at 17:28 UTC)
| Price | USD 107.97 |
|---|---|
| Change | ▲ 0.23% (up) |
| Previous Close | USD 107.72 |
| Open | USD 106.97 |
| Day Range | USD 106.01 – 108.97 |
| 52-Week Range | USD 66.22 – 121.64 |
| Volume | 1,771,548 shares |
| Market Cap | $39.12B |
| Exchange | NYQ |
Technical Analysis (EL)
Nexqual's technical model rates EL "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of October 23, 2026 at 17:28 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 63.35 (neutral) |
| vs SMA50 | Above (USD 98.44) |
| MACD | 3.06 (positive) |
Analyst Ratings (EL)
Wall Street analysts rate EL "Buy" based on 30 analysts, with a mean price target of USD 109.7 (range USD 70–127), per Nexqual as of October 23, 2026 at 17:28 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 30 |
| Mean Target | USD 109.7 |
| High Target | USD 127 |
| Low Target | USD 70 |
| Buy / Hold / Sell | 15 / 14 / 1 |
Earnings (EL)
| Next Earnings Date | 2026-11-02 |
|---|---|
| EPS Estimate | USD 0.51 |
| Revenue Estimate | $3.65B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.39 vs est 0.32 ▲ beat |
| 2026-03-31 | USD 0.91 vs est 0.65 ▲ beat |
| 2025-12-31 | USD 0.89 vs est 0.83 ▲ beat |
| 2025-09-30 | USD 0.32 vs est 0.18 ▲ beat |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
Financials & Fundamentals (EL)
| Total Revenue | $15.05B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +6.30% |
| Gross Margin | +75.49% |
| Operating Margin | +7.00% |
| Profit Margin | +1.21% |
| ROE | +4.75% |
| Debt / Equity | 2.43 |
| Current Ratio | 1.22 |
| Total Cash | $3.50B |
| Total Debt | $9.25B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.32B (8.7% of revenue) |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
Financial Health Score (EL)
Nexqual rates The Estée Lauder Companies Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 17:28 UTC.
| Growth | Solid — Revenue +5% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 75%, operating 7% (last 12 months) |
| Balance Sheet | Weak — $3.50B cash and investments vs $7.31B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $1.32B (last 4 quarters to Jun 2026, SEC), 9% margin |
| Efficiency | Weak — ROE 5%, ROA 5.2% |
Ownership (EL)
| Insider Ownership | +0.29% |
|---|---|
| Institutional Ownership | +96.04% |
| Shares Outstanding | 247.82M |
| Float | 246.31M |
| Short % of Float | +3.02% |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
Leadership (EL)
The Estée Lauder Companies Inc. is led by Stephane de la Faverie, CEO, President & Director, per Nexqual as of October 23, 2026 at 17:28 UTC.
| CEO, President & Director | Stephane de la Faverie |
|---|---|
| Executive VP & CFO | Akhil Shrivastava |
| Chief Technology & Transformation, Data and Analytics Officer | Brian J. Franz |
| Senior Vice President of Corporate Administration | Deborah Krulewitch |
| Senior Vice President Finance & Strategy & Head of Investor Relations | Laraine A. Mancini |
Major Backers & Investors (EL)
Notable institutional backers of The Estée Lauder Companies Inc. include Bank of America Corporation, FMR, LLC, Eagle Capital Management LLC, according to Nexqual as of October 23, 2026 at 17:28 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Bank of America Corporation | 8.57% |
| FMR, LLC | 4.3% |
| Eagle Capital Management LLC | 3.64% |
| Invesco | 2.36% |
| Fidelity | 1.3% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 11.52% |
| BlackRock | 8.41% |
| State Street | 4.66% |
| Geode Capital | 2.69% |
| BNY Mellon | 2.35% |
Source: Nexqual, October 23, 2026 at 17:28 UTC.
From The Estée Lauder Companies Inc.'s Latest SEC 10-K Filing (filed 2026-08-19)
Key Strengths & Strategy (as disclosed to the SEC)
- We have several minority investments as of June 30, 2026, including a company based in India that manufactures, markets and sells Ayurvedic skin care and other products under the Forest Essentials brand name, primarily in India, for which we have signed an agreement, subject to regulatory approvals, to acquire the remaining interest, as well as an investment in a luxury skin care brand, with proprietary formulas designed to support skin repair and resilience at the cellular level.
- A number of our products incorporate patented, patent-pending or proprietary technology.
- Our approach seeks to accelerate the impact of brand-building activities through broad reach media such as print, television and out-of-home advertising, to increase top-of mind awareness, engagement and long-term brand equity and desirability.
- Our marketing and sales executives spend considerable time in the field meeting with consumers, retailers, beauty advisors and makeup artists at the points of sale to enable us to offer a seamless and consistent brand experience across distribution channels.
Partnerships
- We collaborate with a range of expert partners across technology, media, creative services, commerce and data analytics.
Legal & Regulatory Risks (Item 1A, quoted)
- Changes in laws, regulations and policies could adversely affect our business.
- Government reviews, inquiries, investigations and actions could harm our business.
- Risks related to Technology and Cybersecurity Matters
- The compromise or interruption of, or damage to, our information technology (including our operational technology and websites) by cybersecurity incidents, data security breaches, other security problems, design defects or system failures could have a material negative impact on our business.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KVUE | Kenvue Inc. | USD 19.47 | ▼ 2.06% |
| KMB | Kimberly-Clark Corporation | USD 109.59 | ▼ 2.44% |
| CHD | Church & Dwight Company, Inc. | USD 105.64 | ▼ 2.96% |
| CL | Colgate-Palmolive Company | USD 93.88 | ▼ 3.6% |
| UL | Unilever PLC | USD 66 | ▼ 1.49% |
| CLX | Clorox Company (The) | USD 86.09 | ▼ 2.9% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 17:28 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt